©2022 Stanford Medicine
Psychosocial Treatment for Improving Chances of Survival in Women With Breast Cancer
Not Recruiting
Trial ID: NCT00226928
Purpose
This study will investigate the influence of psychosocial treatment on psychological outcomes
and survival among women with metastatic or recurrent breast cancer.
Official Title
Psychosocial Treatment Effects on Cancer Survival
Stanford Investigator(s)
David Spiegel
Jack, Lulu and Sam Willson Professor of Medicine
Eligibility
Inclusion Criteria:
Women were eligible for the study if they had documented metastatic or recurrent breast
cancer, were proficient enough in English to be able to complete questionnaires and
participate in a support group, were living in the Greater San Francisco Bay Area, and had
a Karnofsky score of at least 70%.19 Exclusion Criteria:
Women were excluded if they had any of the following risk factors: positive supraclavicular
lymph nodes as the only metastatic lesion at the time of initial diagnosis; active
non-breast cancers within the past 10 years; or other concurrent medical conditions likely
to influence short-term survival. Basal cell or squamous cell carcinomas of the skin, in
situ cancer of the cervix, or melanoma with a Breslow depth less than 0.76 mm were allowed.
Intervention(s):
behavioral: Supportive-Expressive Group Therapy plus education
behavioral: Education
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305